MELOXICAM AVEXIMA
- Registration number:ЛП-000212
- International non-proprietary name:meloxicam
- Pharmaceutical form:tablets
- Pharmacotherapeutic group:non-steroidal anti-inflammatory drug
- Dosage form:tablets 7.5 mg or 15 mg No. 20
- Composition:active substance: meloxicam - 7.5 mg or 15 mg
MELOXICAM AVEXIMA possesses an anti-inflammatory, antipyretic, analgesic action.
It is important to remember, that Meloxicam more rarely causes erosive and ulcerative gastrointestinal diseases compared to non-selective cyclo-oxygenase inhibitors.
- Indications for use:
-
- rheumatoid arthritis;
- osteoarthritis (arthrosis, degenerative joint diseases), including those with pain syndrome;
- ankylosing spondylitis (Bechterew's disease);
- other inflammatory and degenerative diseases of musculoskeletal system, such as arthropathies, dorsopathies (for example, ischias, lower back pain, humeral periarthritis, etc) accompanied by pain syndrome.
- Method of administration and posology:
-
For oral administration during the meal, not chewing, with water or other liquid, at a daily dose of 7.5-15 mg; dosing frequency - once daily.
Maximal daily dose is 15 mg; for adolescents aged 12-18 years - 0.25 mg/kg (it should not exceed 15 mg).
In patients with severe renal insufficiency on hemodialysis - 7.5 mg.
Symptomatic treatment:
-
In mild to moderate renal impairment (creatinine clearance of more than 30 mL/min) and in liver cirrhosis in case of patient's stable clinical condition, no dose adjustment is required.
Starting dose for patients with increased risk of side effects is 7.5 mg/day.
Combination therapy: the medicinal product should not be used concomitantly with other NSAIDs.
- Shelf life:
-
3 years.
Do not use after the expiry date indicated on the packaging. - Manufacturer
- OJSC "Irbitsky Chemical-Pharmaceutical Plant"
We recommend
-
Antimicrobial agent
-
Antiviral drug
-
Antifungal agent
-
Antimicrobial and antiprotozoal agent.
-
-
Enterosorbent.
-
Antimicrobial agent
-
Spasmolytic agent
-
Antiepileptic agent
-
-
Antifungal agents
-
Calcium channel blocker
-
NOBAZIT®
-
Combination drug
-
Potassium and magnesium preparation
-
Antimicrobial agent
-
Combination drug
-
Antimicrobial and antiprotozoal agent
-
Combination antimicrobial agent
-
-
Non-steroidal anti-inflammatory drug (NSAID)
-
Antimicrobial agent
-
Metabolic agent
-
Antifungal agent
-
Analgesic agent
-
-
antiviral agent, aciclovir
-
-
Antimicrobial agent
-
Enzyme product
-
-
-
Coronary dilating drug